Terms used in patient safety related to medication: A literature review

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 8, 2012, Pages 799-809

  Pintor Mármol, Antonio ^a   Baena, María Isabel ^a   Fajardo, Paloma C ^a   Sabater Hernández, Daniel ^a   Sáez Benito, Loreto ^a   García Cárdenas, María Victoria ^a   Fikri Benbrahim, Narjis ^a   Azpilicueta, Inés ^a   Faus, Maria José ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Medication; Patient safety; Pharmacoepidemiology; Review; Terminology

Indexed keywords

EMBASE; HUMAN; INFORMATION RETRIEVAL; MEDICATION ERROR; MEDLINE; PATIENT COMPLIANCE; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SCIENTIFIC LITERATURE;

DRUG TOXICITY; HUMANS; MEDICATION ERRORS; PATIENT SAFETY; PRESCRIPTION DRUGS; PRODUCT SURVEILLANCE, POSTMARKETING; TERMINOLOGY AS TOPIC;

EID: 84864335454     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3296     Document Type: Review

References (176)

1. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human: Building a Safer Health System. The National Academies Press: Washington, DC, 2000.
2. World Health Organization. World alliance for patient safety: forward programme, 2005. World Health Organization: Geneva, 2004. [26 January 2008].
3. World Alliance for Patient Safety. Forward Programme 2008-2009 (1st edn). World Health Organization: Geneva, 2008. [18 January 2008].
4. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-384.
5. Wilson RM, Runciman WB, Gibberd RW, et al. The Quality in Australian Health Care Study. Med J Aust 1995; 163: 458-471.
6. Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 2000; 38: 261-271.
7. Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals I: occurrence and impact. N Z Med J 2002; 115: U271.
8. Schiøler T, Lipczak H, Pedersen BL, et al. Incidence of adverse events in hospitals. A retrospective study of medical records. Ugeskr Laeger 2001; 163: 5370-5378.
9. Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001; 322: 517-519.
10. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170: 1678-1686.
11. Michel P, Quenon JL, Djihoud A, et al. French national survey of inpatient adverse events prospectively assessed with ward staff. Qual Saf Health Care 2007; 16: 369-377.
12. Aranaz-Andrés JM, Aibar-Remón C, Vitaller-Murillo J, et al. Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events. J Epidemiol Community Health 2008; 62: 1022-1029.
13. Nebeker JR, Hurdle JF, Hoffman J, et al. Developing a taxonomy for research in adverse drug events: potholes and signposts. Proc AMIA Symp, 2001; pp. 493-497.
14. The National Coordinating Council for Medication Error Reporting and Prevention. NCC MERP: The First Ten Years. «Defining the Problem and Developing Solutions». The National Coordinating Council for Medication Error Reporting and Prevention, 2005. [3 April 2009].
15. Bates DW, Boyle DL, Vander Vliet MB, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995; 10: 199-205.
16. McNutt RA, Abrams RI. A model of medical error based on a model of disease: interactions between adverse events, failures, and their errors. Qual Manag Health Care 2002; 10: 23-28.
17. Masotti P, McColl MA, Green M. Adverse events experienced by homecare patients: a scoping review of the literature. Int J Qual Health Care 2010; 22: 115-125.
18. Lisby M, Nielsen LP, Brock B et al. How are medication errors defined? A systematic literature review of definitions and characteristics. Int J Qual Health Care 2010; 22: 507-518.
19. Stelfox HT, Palmisani S, Scurlock C, et al. The«To Err is Human»report and the patient safety literature. Qual Saf Health Care 2006; 15: 174-178.
20. World Health Organization. The Conceptual Framework for the International Classification for Patient Safety (v.1.1). Final Technical Report. World Health Organization: Geneva, 2009. [22 January 2010].
21. Thomson R, Lewalle P, Sherman H, et al. Towards an International Classification for Patient Safety: a Delphi survey. Int J Qual Health Care 2009; 21: 9-17.
22. Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf 2005; 28: 851-870.
23. Yu KH, Nation RL, Dooley MJ. Multiplicity of medication safety terms, definitions and functional meanings: when is enough enough? Qual Saf Health Care 2005; 14: 358-363.
24. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
25. Donabedian A. The quality of medical care. Science 1978; 200: 856-864.
26. Sandora TJ, Goldmann DA. Medical errors detected and corrected by a pediatric infectious diseases consultation service. Infect Control Hosp Epidemiol 2005; 26: 417-420.
27. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-1259.
28. Meyboom RH, Lindquist M, Egberts AC. An ABC of drug-related problems. Drug Saf 2000; 22: 415-423.
29. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795-801.
30. Szekendi MK, Sullivan C, Bobb A, et al. Active surveillance using electronic triggers to detect adverse events in hospitalized patients. Qual Saf Health Care 2006; 15: 184-190.
31. Johnston PE, France DJ, Byrne DW, et al. Assessment of adverse drug events among patients in a tertiary care medical center. Am J Health Syst Pharm 2006; 63: 2218-2227.
32. Ackroyd-Stolarz S, Hartnell N, Mackinnon NJ. Demystifying medication safety: making sense of the terminology. Res Social Adm Pharm 2006; 2: 280-289.
33. Aranaz-Andrés JM, Ruiz-López P, Aibar-Remón C, et al. Adverse events in general and digestive surgery departments in Spanish hospitals. Cir Esp 2007; 82: 268-277.
34. de Vries EN, Ramrattan MA, Smorenburg SM, et al. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care 2008; 17: 216-223.
35. Malpass A, Helps SC, Sexton EJ, et al. A classification for adverse drug events. J Qual Clin Pract 1999; 19: 23-26.
36. Kaboli PJ, Hoth AB, McClimon BJ, et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; 166: 955-964.
37. Ebbesen J, Buajordet I, Erikssen J, et al. Drug-related deaths in a department of internal medicine. Arch Intern Med 2001; 161: 2317-2323.
38. Carlton G, Blegen MA. Medication-related errors: a literature review of incidence and antecedents. Annu Rev Nurs Res 2006; 24: 19-38.
39. Rolland P. Occurrence of dispensing errors and efforts to reduce medication errors at the Central Arkansas Veteran's Healthcare System. Drug Saf 2004; 27: 271-282.
40. Kunac DL, Reith DM, Kennedy J, et al. Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients. Qual Saf Health Care 2006; 15: 196-201.
41. Kopp BJ, Erstad BL, Allen ME, et al. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit Care Med 2006; 34: 415-425.
42. Bumpus L, al-Assaf AF. Using performance improvement strategies to reduce and prevent medication errors. 1. J Cardiovasc Manag 2003; 14: 11-15.
43. Trifirò G, Calogero G, Ippolito FM, et al. Adverse drug events in emergency department population: a prospective Italian study. Pharmacoepidemiol Drug Saf 2005; 14: 333-340.
44. Cimino MA, Kirschbaum MS, Brodsky L, et al. Assessing medication prescribing errors in pediatric intensive care units. Pediatr Crit Care Med 2004; 5: 124-132.
45. Cohen AL, Budnitz DS, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr 2008; 152: 416-421.
46. Grasso BC, Rothschild JM, Genest R, et al. What do we know about medication errors in inpatient psychiatry? Jt Comm J Qual Saf 2003; 29: 391-400.
47. Zandieh SO, Goldmann DA, Keohane CA, et al. Risk factors in preventable adverse drug events in pediatric outpatients. J Pediatr 2008; 152: 225-231.
48. Fortescue EB, Kaushal R, Landrigan CP, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003; 111: 722-729.
49. Morimoto T, Gandhi TK, Seger AC, et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004; 13: 306-314.
50. Hope C, Overhage JM, Seger A, et al. A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events. J Biomed Inform 2003; 36: 92-98.
51. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285: 2114-2120.
52. Gandhi TK, Seger DL, Bates DW. Identifying drug safety issues: from research to practice. Int J Qual Health Care 2000; 12: 69-76.
53. Forster AJ, Halil RB, Tierney MG. Pharmacist surveillance of adverse drug events. Am J Health Syst Pharm 2004; 61: 1466-1472.
54. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-1116.
55. Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006; 184: 321-324.
56. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
57. Buckley MS, Erstad BL, Kopp BJ, et al. Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit. Pediatr Crit Care Med 2007; 8: 145-152.
58. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58: 1126-1132.
59. Takata GS, Taketomo CK, Waite S. Characteristics of medication errors and adverse drug events in hospitals participating in the California Pediatric Patient Safety Initiative. Am J Health Syst Pharm 2008; 65: 2036-2044.
60. Otero López MJ, Codina Jané C, Tamés Alonso MJ, et al. Medication errors: standarizing the terminology and taxomany. Ruiz Jarabo 2000 grand results. Farm Hosp 2003; 27: 137-149.
61. Otero-López MJ, Alonso-Hernández P, Maderuelo-Fernández JA, et al. Preventable adverse drug events in hospitalized patients. Med Clin (Barc) 2006; 126: 81-87.
62. Corral Baena S, Guerrero Aznar MD, Beltrán García M, et al. Use of MBDS as a tool for the detection of drug-related adverse events. Farm Hosp 2004; 28: 258-265.
63. Rousseau MN, Travaglianti M, Vega EM. Pharmacovigilance in a paediatric intensive care unit. Farm Hosp 2006; 30: 249-253.
64. Triller DM, Clause SL, Hamilton RA. Risk of adverse drug events by patient destination after hospital discharge. Am J Health Syst Pharm 2005; 62: 1883-1889.
65. Phillips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835-1841.
66. Cohen MM, Kimmel NL, Benage MK, et al. Medication safety program reduces adverse drug events in a community hospital. Qual Saf Health Care 2005; 14: 169-174.
67. Lazarus HM, Fox J, Evans RS, et al. Adverse drug events in trauma patients. J Trauma 2003; 54: 337-343.
68. Budnitz DS, Pollock DA, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296: 1858-1866.
69. Buajordet I, Wesenberg F, Brørs O, et al. Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital. Acta Paediatr 2002; 91: 88-94.
70. Leendertse AJ, Egberts ACG, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168: 1890-1896.
71. Evans RS, Lloyd JF, Stoddard GJ, et al. Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother 2005; 39: 1161-1168.
72. Hardmeier B, Braunschweig S, Cavallaro M, et al. Adverse drug events caused by medication errors in medical inpatients. Swiss Med Wkly 2004; 134: 664-670.
73. Guchelaar H-J, Colen HBB, Kalmeijer MD, et al. Medication errors: hospital pharmacist perspective. Drugs 2005; 65: 1735-1746.
74. Franceschi A, Tuccori M, Bocci G, et al. Drug therapeutic failures in emergency department patients. A university hospital experience. Pharmacol Res 2004; 49: 85-91.
75. Fanikos J, Cina JL, Baroletti S, et al. Adverse drug events in hospitalized cardiac patients. Am J Cardiol 2007; 100: 1465-1469.
76. Moscoso-Veloza SM, Ramírez-Cubillos GF, López-Gutierrez JJ, et al. Adverse drug reactions in a Suba hospital of Bogotá. Rev Salud Publica (Bogota) 2006; 8: 209-217.
77. Easton-Carter KL, Chapman CB, Brien JE. Emergency department attendances associated with drug-related problems in paediatrics. J Paediatr Child Health 2003; 39: 124-129.
78. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 1331-1336.
79. Burgess CL, Holman CDJ, Satti AG. Adverse drug reactions in older Australians, 1981-2002. Med J Aust 2005; 182: 267-270.
80. Juntti-Patinen L, Neuvonen PJ. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol 2002; 58: 479-482.
81. Suh DC, Woodall BS, Shin SK, et al. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000; 34: 1373-1379.
82. Jonville-Béra AP, Béra F, Autret-Leca E. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur J Clin Pharmacol 2005; 61: 231-236.
83. Tantikul C, Dhana N, Jongjarearnprasert K, et al. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children. Asian Pac J Allergy Immunol 2008; 26: 77-82.
84. Kanneh AB. Adverse drug reactions (ADRs) in children: Part 1. Paediatr Nurs 2004; 16: 32-35.
85. Zhang M, Holman CDJ, Preen DB, et al. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol 2007; 63: 163-170.
86. Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31: 545-556.
87. Temple ME, Robinson RF, Miller JC, et al. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf 2004; 27: 819-829.
88. Brown SD, Landry FJ. Recognizing, reporting, and reducing adverse drug reactions. South Med J 2001; 94: 370-373.
89. Wills S, Brown D. A proposed new means of classifying adverse reactions to medicines. Pharm J 1999; 262: 163-165.
90. Smith KM, Jeske CS, Young B, et al. Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients. Neurosurgery 2006; 58: 426-433.
91. Fernández-Llimós F, Tuneu L, Baena MI, et al. Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems. Curr Pharm Des 2004; 10: 3947-3967.
92. van Mil JWF, Westerlund LOT, Hersberger KE, et al. Drug-related problem classification systems. Ann Pharmacother 2004; 38: 859-867.
93. Comité de Consenso. Third consensus of granada on drug related problems (DRP) and negative outcomes associated with medication (NOM). Ars Pharm 2007; 48: 5-17.
94. Baena MI, Fajardo P, Luque F, et al. Drug related problems in hospital emergency service users: results of the validation of a questionaire. Pharm Care Esp 2001; 3: 345-357.
95. Björkman IK, Sanner MA, Bernsten CB. Comparing 4 classification systems for drug-related problems: processes and functions. Res Social Adm Pharm 2008; 4: 320-331.
96. de Lyra DP, Kheir N, Abriata JP, et al. Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil. Ther Clin Risk Manag 2007; 3: 989-998.
97. Fornos JA, Andrés NF, Andrés JC, et al. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci 2006; 28: 65-72.
98. Baena MI, Faus MJ, Fajardo PC, et al. Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol 2006; 62: 387-393.
99. Baena MI, Fajardo P, Martínez Olmos J, et al. Therapy compliance, patient knowledge of medicines and self-medication as associated factors in negative clinical outcomes in pharmacotherapy. Ars Pharm 2005; 46: 365-381.
100. Espejo J, Fernández-Llimós F, Machuca M, et al. Drug related problems: Definition and proposal for its inclusion in the International Classification of Primary Care (ICPC) from WONCA. Pharm Care Esp 2002; 4: 122-127.
101. Midlöv P, Deierborg E, Holmdahl L, et al. Clinical outcomes from the use of Medication Report when elderly patients are discharged from hospital. Pharm World Sci 2008; 30: 840-845.
102. Nickerson A, MacKinnon NJ, Roberts N, et al. Drug-therapy problems, inconsistencies and omissions identified during a medication reconciliation and seamless care service. Healthc Q 2005; 8: 65-72.
103. Anoz Jiménez L, Borrás Almenar C, Cavera Rodrigo E. Pharmaceutical procedures in patients under treatment with total parenteral nutrition. Farm Hosp 2004; 28: 349-355.
104. Easton KL, Chapman CB, Brien J-anne E. Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 2004; 57: 611-615.
105. Cerulli J, Malone M. Assessment of drug-related problems in clinical nutrition patients. JPEN J Parenter Enteral Nutr 1999; 23: 218-221.
106. Ernst ME, Iyer SS, Doucette WR. Drug-related problems and quality of life in arthritis and low back pain sufferers. Value Health 2003; 6: 51-58.
107. Westerlund T, Almarsdóttir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999; 21: 245-250.
108. Paulino EI, Bouvy ML, Gastelurrutia MA, et al. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci 2004; 26: 353-360.
109. Blix HS, Viktil KK, Moger TA, et al. Use of renal risk drugs in hospitalized patients with impaired renal function--an underestimated problem? Nephrol Dial Transplant 2006; 21: 3164-3171.
110. Blix HS, Viktil KK, Moger TA, et al. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci 2006; 28: 152-158.
111. Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci 2008; 30: 768-776.
112. Gorgas Torner MQ, Gamundi Planas MC, Aguirre Zubia I, et al. The participation of the pharmacist in the design and follow-up of the drug treatment plan for patients with a cardiovascular condition. Farm Hosp 2008; 32: 148-156.
113. Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002; 24: 120-127.
114. Ghaleb MA, Barber N, Franklin BD, et al. Systematic review of medication errors in pediatric patients. Ann Pharmacother 2006; 40: 1766-1776.
115. Kane-Gill S, Weber RJ. Principles and practices of medication safety in the ICU. Crit Care Clin 2006; 22: 273-290, vi.
116. Banning M. Medication errors: professional issues and concerns. Nurs Older People 2006; 18: 27-32.
117. Delgado Sánchez O, Escrivá Torralva A, Vilanova Boltó M, et al. Comparative study of errors in electronic versus manual prescription. Farm Hosp 2005; 29: 228-235.
118. Calabrese AD, Erstad BL, Brandl K, et al. Medication administration errors in adult patients in the ICU. Intensive Care Med 2001; 27: 1592-1598.
119. Kelly WN. Potential risks and prevention, Part 1: Fatal adverse drug events. Am J Health Syst Pharm 2001; 58: 1317-1324.
120. Ferner RE, Aronson JK. Clarification of terminology in medication errors: definitions and classification. Drug Saf 2006; 29: 1011-1022.
121. Barker KN, Flynn EA, Pepper GA, et al. Medication errors observed in 36 health care facilities. Arch Intern Med 2002; 162: 1897-1903.
122. Schneider MP, Cotting J, Pannatier A. Evaluation of nurses' errors associated in the preparation and administration of medication in a pediatric intensive care unit. Pharm World Sci 1998; 20: 178-182.
123. van Gijssel-Wiersma DG, van den Bemt PMLA, Walenbergh-van Veen MCM. Influence of computerised medication charts on medication errors in a hospital. Drug Saf 2005; 28: 1119-1129.
124. LaPointe NMA, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med 2003; 163: 1461-1466.
125. Jornet Montaña S, Canadell Vilarrasa L, Calabuig Mũoz M, et al. Detection and classification of medication errors at Joan XXIII University Hospital. Farm Hosp 2004; 28: 90-96.
126. Woods A, Doan-Johnson S. Executive summary: toward a taxonomy of nursing practice errors. Nurs Manage 2002; 33: 45-48.
127. Otero López MJ, Castaño Rodríguez B, Pérez Encinas M, et al. Updated classification for medication errors by the Ruiz-Jarabo 2000 Group. Farm Hosp 2008; 32: 38-52.
128. Calderón Hernanz B, Santolaya Perrín R, Pérez Sanz C, et al. Error detection in the administration of antiretroviral therapy to out-patients. Farm Hosp 2004; 28: 201-204.
129. Díaz-Carrasco MS, Pareja A, Yachachi A, et al. Prescription errors in chemotherapy. Farm Hosp 2007; 31: 161-164.
130. Forrey RA, Pedersen CA, Schneider PJ. Interrater agreement with a standard scheme for classifying medication errors. Am J Health Syst Pharm 2007; 64: 175-181.
131. Pinilla J, Murillo C, Carrasco G, et al. Case-control analysis of the financial cost of medication errors in hospitalized patients. Eur J Health Econ 2006; 7: 66-71.
132. Wolf ZR, Hicks R, Serembus JF. Characteristics of medication errors made by students during the administration phase: a descriptive study. J Prof Nurs 2006; 22: 39-51.
133. Garzás-Martín de Almagro MC, López-Malo de Molina MD, Abellón Ruiz J, et al. Pharmaceutical validation and error detection in the prescription of antineoplastics in oncohematological patients. Farm Hosp 2008; 32: 286-289.
134. Hicks RW, Becker SC, Cousins DD. Harmful medication errors in children: a 5-year analysis of data from the USP's MEDMARX program. J Pediatr Nurs 2006; 21: 290-298.
135. Beyea SC, Kobokovich LJ, Becker SC, et al. Medication errors in the LDRP. AWHONN Lifelines 2004; 8: 130-140.
136. Slama C, Jerome J, Jacquot C, et al. Prescription errors with cytotoxic drugs and the inadequacy of existing classifications. Pharm World Sci 2005; 27: 339-343.
137. Gandhi TK, Bartel SB, Shulman LN, et al. Medication safety in the ambulatory chemotherapy setting. Cancer 2005; 104: 2477-2483.
138. Miller MR, Clark JS, Lehmann CU. Computer based medication error reporting: insights and implications. Qual Saf Health Care 2006; 15: 208-213.
139. Phatak HM, Cady PS, Heyneman CA, et al. Retrospective detection of potential medication errors involving drugs with similar names. J Am Pharm Assoc 2005; 45: 616-621; quiz 622-4.
140. Hansen RA, Greene SB, Williams CE, et al. Types of medication errors in North Carolina nursing homes: a target for quality improvement. Am J Geriatr Pharmacother 2006; 4: 52-61.
141. Hughes RG, Ortiz E. Medication errors: why they happen, and how they can be prevented. J Infus Nurs 2005; 28: 14-24.
142. Bhasale AL, Miller GC, Reid SE, et al. Analysing potential harm in Australian general practice: an incident-monitoring study. Med J Aust 1998; 169: 73-76.
143. Ashcroft DM, Quinlan P, Blenkinsopp A. Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies. Pharmacoepidemiol Drug Saf 2005; 14: 327-332.
144. Ito H, Yamazumi S. Common types of medication errors on long-term psychiatric care units. Int J Qual Health Care 2003; 15: 207-212.
145. Sawamura K, Ito H, Yamazumi S, et al. Interception of potential adverse drug events in long-term psychiatric care units. Psychiatry Clin Neurosci 2005; 59: 379-384.
146. AbuRuz SM, Bulatova NR, Yousef AM. Validation of a comprehensive classification tool for treatment-related problems. Pharm World Sci 2006; 28: 222-232.
147. Hughes CM, Wright RM, Lapane KL. Use of medication technicians in US nursing homes: part of the problem or part of the solution? J Am Med Dir Assoc 2006; 7: 294-304.
148. Kelly WN. Potential risks and prevention, Part 2: Drug-induced permanent disabilities. Am J Health Syst Pharm 2001; 58: 1325-1329.
149. Marcellino K, Kelly WN. Potential risks and prevention, Part 3: Drug-induced threats to life. Am J Health Syst Pharm 2001; 58: 1399-1405.
150. Kelly WN. Potential risks and prevention, Part 4: Reports of significant adverse drug events. Am J Health Syst Pharm 2001; 58: 1406-1412.
151. Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients. J Gen Intern Med 2000; 15: 149-154.
152. Fattinger K, Roos M, Vergères P, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 2000; 49: 158-167.
153. Beso A, Franklin BD, Barber N. The frequency and potential causes of dispensing errors in a hospital pharmacy. Pharm World Sci 2005; 27: 182-190.
154. Kanjanarat P, Winterstein AG, Johns TE, et al. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003; 60: 1750-1759.
155. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm 2002; 59: 2089-2092.
156. Purdy BD, Raymond AM, Lesar TS. Antiretroviral prescribing errors in hospitalized patients. Ann Pharmacother 2000; 34: 833-838.
157. Howard RL, Avery AJ, Howard PD, et al. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003; 12: 280-285.
158. Hollanda J. A role for morbidity and mortality conferences in psychiatry. Australas Psychiatry 2007; 15: 338-342.
159. Van Vorst RF, Araya-Guerra R, Felzien M, et al. Rural community members' perceptions of harm from medical mistakes: a High Plains Research Network (HPRN) Study. J Am Board Fam Med 2007; 20: 135-143.
160. Lesar TS. Prescribing errors involving medication dosage forms. J Gen Intern Med 2002; 17: 579-587.
161. Dean B, Schachter M, Vincent C, et al. Prescribing errors in hospital inpatients: their incidence and clinical significance. Qual Saf Health Care 2002; 11: 340-344.
162. Humphries TL, Carroll N, Chester EA, et al. Evaluation of an electronic critical drug interaction program coupled with active pharmacist intervention. Ann Pharmacother 2007; 41: 1979-1985.
163. Varkey P, Aponte P, Swanton C, et al. The effect of computerized physician-order entry on outpatient prescription errors. Manag Care Interface 2007; 20: 53-57.
164. Thomas AN, Panchagnula U. Medication-related patient safety incidents in critical care: a review of reports to the UK National Patient Safety Agency. Anaesthesia 2008; 63: 726-733.
165. Malone DC, Abarca J, Skrepnek GH, et al. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions. Med Care 2007; 45: 456-462.
166. Rubin G, George A, Chinn DJ, et al. Errors in general practice: development of an error classification and pilot study of a method for detecting errors. Qual Saf Health Care 2003; 12: 443-447.
167. Dean B, Barber N, Schachter M. What is a prescribing error? Qual Health Care 2000; 9: 232-237.
168. Rees S, Thomas P, Shetty A, et al. Drug history errors in the acute medical assessment unit quantified by use of the NPSA classification. Pharm J 2007; 279: 469-471.
169. The World Alliance For Patient Safety Drafting Group, Sherman H, Castro G, et al. Towards an International Classification for Patient Safety: the conceptual framework. Int J Qual Health Care 2009; 21: 2-8.
170. Runciman W, Hibbert P, Thomson R, et al. Towards an International Classification for Patient Safety: key concepts and terms. Int J Qual Health Care 2009; 21: 18-26.
171. Rissato Mde A, Romano-Lieber NS, Lieber RR. Terminology for drug incidents in the hospital context. Cad Saude Publica 2008; 24: 1965-1975.
172. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-543.
173. Baena MI, Martínez Olmos J, Faus MJ, et al. Pharmacotherapy follow-up: as a quality component in patient care. Ars Pharm 2005; 46: 213-232.
174. Easton K, Morgan T, Williamson M. Medication safety in the community: A review of the literature. National Prescribing Service: Sydney, 2009.
175. Fernandez-Llimos F, Faus MJ. From«drug-related problems»to«negative clinical outcomes». Am J Health Syst Pharm 2005; 62: 2348-2350.
176. Gastelurrutia P, Benrimoj SI, Espejo J, et al. Negative Clinical Outcomes Associated With Drug-Related Problems in Heart Failure (HF) Outpatients: Impact of a Pharmacist in a Multidisciplinary HF Clinic. J Card Fail 2011; 17: 217-223.